| A review of food–drug interactions on oral drug absorption J Deng, X Zhu, Z Chen, CH Fan, HS Kwan, CH Wong, KY Shek, Z Zuo, ... Drugs 77, 1833-1855, 2017 | 162 | 2017 |
| Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID‐19 R Peña‐Silva, SB Duffull, AC Steer, SX Jaramillo‐Rincon, A Gwee, X Zhu British journal of clinical pharmacology 87 (3), 1589, 2021 | 71 | 2021 |
| Imaging acidosis in tumors using a pH-activated near-infrared fluorescence probe L Wang, X Zhu, C Xie, N Ding, X Weng, W Lu, X Wei, C Li Chemical communications 48 (95), 11677-11679, 2012 | 58 | 2012 |
| Disease progression model of 4T1 metastatic breast cancer L Yang, L Yong, X Zhu, Y Feng, Y Fu, D Kong, W Lu, T Zhou Journal of pharmacokinetics and pharmacodynamics 47, 105-116, 2020 | 31 | 2020 |
| Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients X Ji, S Ji, X He, X Zhu, R Chen, W Lu Acta Pharmacologica Sinica 39 (2), 286-293, 2018 | 25 | 2018 |
| Model‐free and kinetic modelling approaches for characterising non‐equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB1 receptors X Zhu, DB Finlay, M Glass, SB Duffull British Journal of Pharmacology 176 (14), 2593-2607, 2019 | 24 | 2019 |
| Population pharmacokinetics of levetiracetam: a systematic review Z Li, C Wang, X Zhu, Z Jiao Clinical Pharmacokinetics 60, 305-318, 2021 | 23 | 2021 |
| Pharmacokinetic-pharmacodynamic modeling of the anti-tumor effect of sunitinib combined with dopamine in the human non-small cell lung cancer xenograft F Hao, S Wang, X Zhu, J Xue, J Li, L Wang, J Li, W Lu, T Zhou Pharmaceutical research 34, 408-418, 2017 | 18 | 2017 |
| An evaluation of the operational model when applied to quantify functional selectivity X Zhu, DB Finlay, M Glass, SB Duffull British Journal of Pharmacology 175 (10), 1654-1668, 2018 | 16 | 2018 |
| Research and development of Chinese anti-COVID-19 drugs X Ji, X Meng, X Zhu, Q He, Y Cui Acta Pharmaceutica Sinica B 12 (12), 4271-4286, 2022 | 15 | 2022 |
| Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling X Zhu, DB Finlay, M Glass, SB Duffull British Journal of Pharmacology 177 (15), 3449-3463, 2020 | 14 | 2020 |
| Model‐based analysis on systemic availability of co‐administered cannabinoids after controlled vaporised administration Z Liu, P Galettis, SJ Broyd, H van Hell, LM Greenwood, P de Krey, ... Internal Medicine Journal 50 (7), 846-853, 2020 | 14 | 2020 |
| Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice X Ji, S Ji, R Li, K Wu, X Zhu, W Lu, T Zhou Acta Pharmacologica Sinica 37 (6), 825-833, 2016 | 14 | 2016 |
| Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children A Gwee, S Duffull, X Zhu, SYC Tong, N Cranswick, B McWhinney, ... PLoS neglected tropical diseases 14 (12), e0008886, 2020 | 13 | 2020 |
| Mechanistic pharmacokinetic/pharmacodynamic model of sunitinib and dopamine in MCF-7/adr xenografts: Linking cellular heterogeneity to tumour burden S Wang, X Zhu, M Han, F Hao, W Lu, T Zhou The AAPS Journal 22, 1-13, 2020 | 10 | 2020 |
| Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients Y Chen, Z Liu, R Chen, L Wang, L Huang, X Zhu, T Zhou, W Lu, P Ma Acta Pharmacologica Sinica 38 (8), 1195-1204, 2017 | 10 | 2017 |
| Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS Z Feng, X Li, WK Tong, Q He, X Zhu, X Xiang, Z Tang Frontiers in Pharmacology 13, 894685, 2022 | 9 | 2022 |
| Application of physiologically based pharmacokinetic modeling in preclinical studies: A feasible strategy to practice the principles of 3Rs Y Yuan, Q He, S Zhang, M Li, Z Tang, X Zhu, Z Jiao, W Cai, X Xiang Frontiers in Pharmacology 13, 895556, 2022 | 9 | 2022 |
| Model-informed drug development, pharmacokinetic/pharmacodynamic cutoff value determination, and antibacterial efficacy of benapenem against Enterobacteriaceae X Ji, F Xue, Z Kang, W Zhong, IH Kuan, X Yang, X Zhu, Y Li, Y Lv Antimicrobial Agents and Chemotherapy 64 (3), 10.1128/aac. 01751-19, 2020 | 9 | 2020 |
| Comparison of infrared-assisted extraction and other techniques for analysis of indigo and indirubin in leaves of isatis indigotica fort Y Chen, X Zhu, Y Yu, Y Cai, Y Li, G Duan Journal of liquid chromatography & related technologies 35 (3), 362-374, 2012 | 9 | 2012 |
Michelle GlassUniversity of OtagoGeverifieerd e-mailadres voor otago.ac.nz
